Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hubbell Reports Third Quarter 2026 Results
-
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
-
Weatherford Announces Court Approval and Expected Closing Date for U.S. Redomestication
-
FTI Consulting Adds Neel Malkani to Help Private Capital Firms and Portfolio Companies Accelerate Value Creation
-
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
-
SATO Corporation’s financial reports and AGM in 2027
-
Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT plc - Ordinary Shares
-
Peptide Stacks: Kylo Peptides Brings Wolverine, GLOW and KLOW Into One Research Stack Line
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Stellar Pictures Showcases Premium Productions at MIPCOM Cannes, Bringing Eastern Aesthetics to Global Audiences
-
Lumion Highlights AI Agents for After-Hours Inquiries and Lead Follow-Up
-
Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131
-
Flow Capital Announces Trading Symbol Change to “FLOW”
-
AI Readiness Drives Organizational Impact
-
Sekoia brings modern security operations to government, defense and critical infrastructure with new self-hosted deployment
-
RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - Rotork plc
-
Mammogen and MammoLink Partner to Advance a New Model for Community-Based Breast Cancer Detection
-
NexGold Reports Progress on Development Activities at the Goldboro Gold Project in Nova Scotia
-
Man Group PLC : Form 8.3 - Vesuvius Plc
-
NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026
-
Anfield Energy Receives Draft Renewed Radioactive Materials License and Draft Groundwater Discharge Permit for Shootaring Canyon Mill from Utah DWMRC
-
Media Advisory: MADD Canada’s Project Red Ribbon to Honour Two Pillars of the Bangladeshi Community
-
George Weston Limited Announces Timing of Third Quarter Earnings Release
-
OutSolve Acquires Legets, Adding AI Horsepower to its HR Compliance as a Service Solution
-
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
-
Questor Appoints Audrey Mascarenhas President and Chief Executive Officer
-
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
-
The Simply Good Foods Company Reports Fiscal Fourth Quarter and Full Fiscal Year 2026 Financial Results and Provides Fiscal Year 2027 Outlook
-
Global Financial News from MT Newswires Now Live in Microsoft Copilot
-
Presenting on Emerging Growth Conference 97 Day 1 on October 28; Register to live stream
-
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pa
-
Manual Links Marks Five Years as a Manual Link Building Service, With More Than 300 SaaS and Healthcare Brands Served
-
Luckin Coffee to Announce Third Quarter 2026 Financial Results on November 3, 2026
-
SunPower Expands in Texas with SOLRITE Virtual Power Plant Partnership
-
Foremost Reports Assay Results from Tuning Fork Uranium Zone Including High-Grade Highlight of 1.3% U₃O₈ over 1.0 Metre
-
Aeluma to Participate in Upcoming Investor Conferences
-
Osisko Gold Provides Construction Progress Update on the Cariboo Gold Project
-
Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast
-
ButcherBox Takes a Stand on Antibiotics in School Meals on Capitol Hill
-
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual
-
Factorial Sets Date for Third Quarter 2026 Results
-
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
-
TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet
-
Fortrea to Participate in Jefferies Global Healthcare Conference
-
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
-
Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience
-
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
